Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Noteableon Jun 14, 2024 10:54am
36 Views
Post# 36089149

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Multiple thoughts.

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Multiple thoughts.

" Aras Agalarov made a suitable sherpa. While not a member of Putin’s inner circle, Agalarov cultivated friendly relations with the Kremlin while rising to the country’s oligarch class with a profitable network of shopping malls. He travelled around in a $44m Gulfstream private jet.

Less than two weeks before the Miss Universe finals, Putin awarded Agalarov the prestigious Order of Honor medal, after Crocus had completed for him a billion-dollar transformation of a former military base into a new state university. 

Separately, one of Agalarov’s top executives, Irakly “Ike” Kaveladze, also has his own relationships with several influential Russians. Kaveladze, a publicity-shy Crocus vice president, was the so-called “eighth man” at the 2016 Trump Tower meeting where Donald Jr hoped to receive dirt on Clinton.

While relatively unknown to the public before news of the meeting emerged in July, Kaveladze has in fact been an associate of some of Russia’s richest and most powerful people for the past three decades.

The Guardian has established that Kaveladze was involved in the $341m takeover of a US company by a Russian mining firm belonging to an associate of Putin, and was a business partner to two former senior officials at Russia’s central bank.

The deal was the first time a Russian company had ever taken a majority stake in a publicly traded US company. It was viewed as critical by the Kremlin. Putin was reported at the time to have personally advocated for the deal’s approval by US regulators during a meeting with then president George W Bush earlier in 2003."

<< Previous
Bullboard Posts
Next >>